secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2026-06-12T20:10:18+00:00
Accession:  0001213900-26-068272
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx shareholders OK 1M-share equity plan increase; reject evergreen auto-increase
--------------------------------------------------------------------------------

- Shareholders approved amendment to 2021 Equity Plan raising share cap from 4.45M to 5.45M shares (11,541,123 for, 1,096,197 against).
- Evergreen provision for automatic annual share increases was rejected: 5,627,324 for, 7,001,699 against.
- Seven directors elected with votes ranging from 8.1M to 12.2M for; advisory say-on-pay passed with 11.7M votes in favor.
- Grant Thornton LLP ratified as independent auditor for FY2026 with 15.8M votes in favor.
- CEO Stephen Silvestro received the highest director vote (12.2M for) and remains Chief Executive Officer & Director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000121390026068272/0001213900-26-068272-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000121390026068272/ea0294565-8k_optimize.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-068272

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer